Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 2/20 | 0.32 |
| ▸ | BRD2 | P25440 | 1/20 | 0.32 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.30 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.30 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17952325 | 0.91 | KDM4E (0.34) | KDM4EALDH1A1GLAGAABRD4 | |
| SCHEMBL17952337 | 0.91 | GAA (0.34) | KDM4EALDH1A1GLAGAABRD4 | |
| SCHEMBL17952196 | 0.86 | SMN1; SMN2 (0.36) | KDM4EALDH1A1GLAGAAEGLN1 | |
| SCHEMBL17952277 | 0.86 | ALDH1A1 (0.36) | KDM4EALDH1A1GLAGAACYP11B1 | |
| SCHEMBL17952113 | 0.86 | TSHR (0.36) | KDM4EALDH1A1GLAGAA | |
| SCHEMBL17952253 | 0.85 | GABRA1 (0.37) | BRD4BRD2BRD3EGLN1CYP11B1 | |
| SCHEMBL17952117 | 0.85 | NPSR1 (0.33) | KDM4EALDH1A1GAA | |
| SCHEMBL17952318 | 0.85 | ALDH1A1 (0.37) | KDM4EALDH1A1GLAGAABRD4 | |
| SCHEMBL17952284 | 0.84 | ALDH1A1 (0.35) | KDM4EALDH1A1GLAGAABRD4 | |
| SCHEMBL17952274 | 0.84 | ALDH1A1 (0.36) | KDM4EALDH1A1GLAGAAEGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP2 | KDM4E 4426/4885ALDH1A1 1620/4885GLA 1850/4885 |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP2 | KDM4E 4426/4885ALDH1A1 1620/4885GLA 1850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.